ArticleJournal of thoracic disease2023

Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma.

Zijian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.